Genzyme Corporate Research Search Genzyme Websites
Information for Fabry Disease patients and their familiesFabry disease treatment information for health care professionals
Fabrazyme This website is intended for use in the United States. Please visit the Genzyme website for your country or region.
Patients and Families
About Fabry Disease
Genetics and Fabry
Signs and Symptoms
Diagnosis
Living with Fabry
About Fabrazyme
Treatment
Support and Resources
Product Information
Genzyme Fabrazyme

About Fabry Disease

Fabry disease is an inherited condition that affects only a few thousand people worldwide. Fabry disease causes a wide range of signs and symptoms that can range from mild to severe and life-threatening.

How Fabry Disease Affects the Body

Our bodies contain thousands of active substances called enzymes. In people without Fabry disease, the enzyme alpha-galactosidase A (pronounced al-fa-ga-lak-toe-si-daze a), or alpha-GAL, helps the body to break down a fatty substance called globotriaosylceramide (pronounced glow-bow-tri-oh-syl-ser-a-mide), or GL-3.

People with Fabry disease are missing or have insufficient amounts of the alpha-GAL enzyme, which is important in the healthy functioning of organs. The alpha-GAL enzyme is responsible for removing a fatty substance, GL-3, from cells throughout the body. Without enough of this enzyme, the GL-3 substance builds up in cells. GL-3 build-up in kidney cells may cause severe kidney problems, including kidney failure.

People with Fabry disease may experience a wide range of signs and symptoms, including severe conditions such as kidney failure, heart problems, and stroke.

The illustrations below show how unaffected cells can clear GL-3 (left), whereas GL-3 builds up in cells affected by Fabry disease (right).

Learn more about Fabry disease at Genzyme's Fabry Community website. This website contains additional information on signs and symptoms, how the disease is inherited, and how females are affected. Fabry Community also offers resources for people living with Fabry disease, their families, and their healthcare providers.


Keyword: 
Search In: 
Highlight

About Fabrazyme

Fabrazyme is enzyme replacement therapy for use in patients with Fabry disease. More >


Resources

Insurance and Reimbursement
Information Request
Ask Us
Learn About the Fabry Registry
Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
617 768 9000
800 745 4447
Contact Us
 
This website is intended for use in the United States. Please visit the Genzyme website for your country or region.



Terms and Conditions of Use | Privacy Policy | © 2003-2010 Genzyme Corporation. All rights reserved. |  Fabr/US/P133/11/09 |  Site Map
Genzyme Therapeutics